Pre-earnings brief
Reports
Tue, Oct 27, 2026
Est. EPS
—
Est. revenue
—
Implied move
±7.8%
EPS beat rate
75%
HCA Healthcare, Inc. is a leading provider of health care services in the United States, operating hospitals and outpatient facilities. As a major player in the health care sector, its performance is closely tied to trends in patient volume, insurance reimbursement rates, and overall health care spending.
Last quarter
In Q2 2026, HCA reported an EPS of $7.59, slightly beating expectations. The stock reacted positively, gaining 1.51% the following day.
Management promises and guidance
EPS beat streak
1Q
EPS beat rate
75%
Avg EPS surprise
+7.12%
Avg 1-day reaction
-2.16%
Analysts are cautiously optimistic about HCA's upcoming earnings, expecting continued growth in EPS and patient volumes. However, there are concerns about rising costs and reimbursement pressures.
Bull case
If HCA can demonstrate strong patient volume growth and improved margins, it could lead to significant upward revisions in earnings expectations.
Bear case
Conversely, if the company reports weaker-than-expected patient volumes or rising operational costs, it could lead to a sharp decline in stock price.
The print will turn on these.
Q1
What is the growth rate of patient volumes this quarter?
Patient volume growth is crucial for revenue and profitability, and any significant change could impact market sentiment.
Q2
How are operational costs trending relative to revenue?
Understanding cost management will be key to assessing the company's profitability and future guidance.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±10.3%
Why consensus could be wrong
The Street may be underestimating HCA's ability to leverage outpatient services for growth, which could lead to better-than-expected patient volume increases.
Supporting evidence
Recent trends in outpatient care suggest a shift in patient preferences that HCA is well-positioned to capitalize on.
The options market is pricing a larger move than historical averages, indicating that traders expect significant volatility.
Key risk
If patient volumes exceed 5% growth, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance hinges on how well HCA can manage costs while driving patient volume growth amid industry pressures.
Bull confirmed if
A patient volume growth rate of over 5% would confirm the bullish outlook.
Bear confirmed if
A decline in patient volumes or an increase in operational costs beyond 3% would support the bearish view.
What the market is pricing for the move.
Implied Move
±7.77%
Historical Avg
±4.7%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings report.
Options are pricing ±7.8% while HCA has averaged ±4.7% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
26.5%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 11 of 30 (37%)
This setup has occurred 30 times across Health Care in the last 2 years. 19 of 30 (63%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 3.2%, with a raw directional average of -0.6% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
78.87%
of float
Insider
16.61%
of float
Holders
1,864
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
13,003,600 sh · $5.7B
6.01%
-2.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If HCA beats expectations, history suggests the stock could rise by around 0.06% on the first day, confirming a positive outlook.
In line / cautious
A cautious inline report may lead to muted reactions as investors await further clarity on future growth.
Miss
If the company misses expectations, history indicates a potential drop of about 8.82%, reflecting investor disappointment.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
1 buy·0 sells
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Capital Management LLC
10,141,708 sh · $4.5B
4.68%
-0.4%
Sanders Capital, LLC
8,828,287 sh · $3.9B
4.08%
-1.4%
State Street Corporation
7,469,035 sh · $3.3B
3.45%
-0.9%
Wellington Management Group, LLP
4,707,473 sh · $2.1B
2.17%
20.5%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net buying
Recent Transactions
Traded Jun 17, 2026 · disclosed Jul 26, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.